Bayer AG ’s Nexavar treatment for advanced liver cancer will be tested against a radiotherapy made by Sirtex Medical Ltd. in a final-stage study of patients in the Asia-Pacific region.
A radiation treatment that attacks cancer in the liver from the inside is putting Sirtex Medical Ltd. back into the takeover spotlight.
Celsion Corp. plunged the most ever in New York trading after the company announced its experimental treatment for liver cancer failed in a study.
A genetically modified smallpox vaccine shrunk tumors in liver cancer patients and extended survival more than a year, a study found.
Gilead Sciences Inc.’s hepatitis C drug Sovaldi offers a benefit for patients, though the extent to which it prevents liver cancer is unclear, according to Germany’s drug-review panel.
Bayer AG and Onyx Pharmaceuticals Inc.’s drug Nexavar gave thyroid cancer patients a five-month respite from their tumors getting worse in a study that will be used to request broader marketing approval for the medicine.